Kawasaki, Japan

Mototsugu Yamada

This inventor holds 1 USPTO granted patent. Top assignee: Meiji Seika Pharma Co., Ltd.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mototsugu Yamada. Retrieved from https://idiyas.com/inventor/mototsugu-yamada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mototsugu Yamada: Innovator in Antibacterial Research

Introduction

Mototsugu Yamada is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of antibacterial research, particularly through his innovative work on NDM inhibitors. His research aims to combat the challenges posed by antibiotic resistance.

Latest Patents

Mototsugu Yamada holds a patent for an NDM inhibitor. The objective of this invention is to provide a novel NDM (New Delhi metallo-β-lactamase) inhibitor that functions as a drug for restoring the antibacterial activity of β-lactam antibiotics that have been inactivated due to decomposition by NDM. The patent describes a compound represented by a specific general formula, which is crucial for its effectiveness.

Career Highlights

Yamada is associated with Meiji Seika Pharma Co., Ltd., where he continues to advance his research in the pharmaceutical industry. His work is vital in addressing the growing concern of antibiotic resistance, which poses a significant threat to public health.

Collaborations

Mototsugu Yamada has collaborated with notable colleagues, including Akihiro Morinaka and Kazunori Maebashi. These partnerships enhance the research efforts and contribute to the development of effective antibacterial solutions.

Conclusion

Mototsugu Yamada's innovative work in developing NDM inhibitors represents a critical advancement in the fight against antibiotic resistance. His contributions are essential for improving the efficacy of existing antibiotics and ensuring better health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…